Cardiac Manifestation among Children with Hemolytic Uremic Syndrome.
Journal
The Journal of pediatrics
ISSN: 1097-6833
Titre abrégé: J Pediatr
Pays: United States
ID NLM: 0375410
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
29
06
2020
revised:
25
03
2021
accepted:
29
03
2021
pubmed:
6
4
2021
medline:
23
11
2021
entrez:
5
4
2021
Statut:
ppublish
Résumé
The primary objectives of the study were to describe the association between cardiac manifestations and in-hospital mortality among children with hemolytic uremic syndrome. Using the Pediatric Health Information System database, this retrospective, multicenter, cohort study identified the first hemolytic uremic syndrome-related inpatient visit among children ≤18 years (years 2004-2018). The frequency of selected cardiac manifestations and mortality rates were calculated. Multivariate analysis identified the association of specific cardiac manifestations and the risk of in-hospital mortality. Among 3915 patients in the analysis, 238 (6.1%) had cardiac manifestations. A majority of patients (82.8%; n = 197) had 1 cardiac condition and 17.2% (n = 41) had ≥2 cardiac conditions. The most common cardiac conditions was pericardial disease (n = 102), followed by congestive heart failure (n = 46) and cardiomyopathy/myocarditis (n = 34). The percent mortality for patients with 0, 1, or ≥2 cardiac conditions was 2.1%, 17.3%, and 19.5%, respectively. Patients with any cardiac condition had an increased odds of mortality (OR, 9.74; P = .0001). In additional models, the presence of ≥2 cardiac conditions (OR, 9.90; P < .001), cardiac arrest (OR, 38.25; P < .001), or extracorporeal membrane oxygenation deployment (OR, 11.61; P < .001) were associated with increased risk of in-hospital mortality. This study identified differences in in-hospital mortality based on the type of cardiac manifestations, with increased risk observed for patients with multiple cardiac involvement, cardiac arrest, and extracorporeal membrane oxygenation deployments.
Identifiants
pubmed: 33819463
pii: S0022-3476(21)00316-4
doi: 10.1016/j.jpeds.2021.03.067
pmc: PMC8316308
mid: NIHMS1701179
pii:
doi:
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
144-148.e4Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR003107
Pays : United States
Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Références
Pediatr Nephrol. 2013 Nov;28(11):2097-105
pubmed: 23288350
Pediatr Nephrol. 1994 Dec;8(6):754-5
pubmed: 7696120
Pediatr Nephrol. 1997 Apr;11(2):221-2
pubmed: 9090671
Nephrol Dial Transplant. 2009 Feb;24(2):679-81
pubmed: 19033247
J Pediatr Intensive Care. 2020 Dec;9(4):290-294
pubmed: 33133747
Pediatrics. 2006 May;117(5):1656-62
pubmed: 16651320
Clin Infect Dis. 2017 Jun 15;64(12):1637-1643
pubmed: 28329394
Clin Infect Dis. 2009 Nov 15;49(10):1480-5
pubmed: 19827953
Eur J Pediatr. 2016 Dec;175(12):1927-1931
pubmed: 27659663
J AHIMA. 2004 Nov-Dec;75(10):22-6
pubmed: 15559835
Pediatr Cardiol. 2005 Jan-Feb;26(1):104-6
pubmed: 15136901
J Pediatr. 1964 Apr;64:478-91
pubmed: 14141006
Pediatr Nephrol. 2017 Nov;32(11):2155-2158
pubmed: 28780656
Paediatr Anaesth. 2007 Jun;17(6):584-7
pubmed: 17498023
Pediatr Nephrol. 2003 Mar;18(3):286-9
pubmed: 12644926
Arch Dis Child. 1995 Jan;72(1):46-7
pubmed: 7717737
Nephrol Dial Transplant. 1998 Sep;13(9):2419-20
pubmed: 9761544
Pediatr Nephrol. 1995 Feb;9(1):117-9
pubmed: 7742210
J Pediatr. 2015 Apr;166(4):1022-9
pubmed: 25661408
Am J Med. 2005 May;118(5):544-7
pubmed: 15866258
Am J Dis Child. 1971 Nov;122(5):418-20
pubmed: 4943015
Br Heart J. 1987 Feb;57(2):181-3
pubmed: 3814452
Curr Opin Pediatr. 2005 Apr;17(2):200-4
pubmed: 15800412